Clinical considerations and challenges in TAV-in-TAV procedures.

CT planning TAV-in-TAV TAVR coronary obstruction structural valve deterioration

Journal

Frontiers in cardiovascular medicine
ISSN: 2297-055X
Titre abrégé: Front Cardiovasc Med
Pays: Switzerland
ID NLM: 101653388

Informations de publication

Date de publication:
2024
Historique:
received: 07 11 2023
accepted: 24 01 2024
medline: 5 3 2024
pubmed: 5 3 2024
entrez: 5 3 2024
Statut: epublish

Résumé

Transcatheter aortic valve replacement (TAVR) has emerged as a viable treatment for aortic valve disease, including low-risk patients. However, as TAVR usage increases, concerns about long-term durability and the potential for addition interventions have arisen. Transcatheter aortic valve (TAV)-in-TAV procedures have shown promise in selected patients in numerous registries, offering a less morbid alternative to TAVR explantation. In this review, the authors aimed to comprehensively review the experience surrounding TAV-in-TAV, summarize available data, discuss pre-procedural planning, highlight associated challenges, emphasize the importance of coronary obstruction assessment and provide insights into the future of this technique.

Identifiants

pubmed: 38440208
doi: 10.3389/fcvm.2024.1334871
pmc: PMC10910030
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

1334871

Informations de copyright

© 2024 Hayek, Prieur, Dürrleman, Chatelain, Ibrahim, Asgar, Modine and Ben Ali.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The authors declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

Auteurs

Ahmad Hayek (A)

Structural Heart Intervention Program, Montreal Heart Institute, Montreal, QC, Canada.
Department of Interventional Cardiology, Hospices Civils de Lyon, Lyon, France.

Cyril Prieur (C)

Department of Interventional Cardiology, Hospices Civils de Lyon, Lyon, France.

Nicolas Dürrleman (N)

Structural Heart Intervention Program, Montreal Heart Institute, Montreal, QC, Canada.

Quentin Chatelain (Q)

Structural Heart Intervention Program, Montreal Heart Institute, Montreal, QC, Canada.

Reda Ibrahim (R)

Structural Heart Intervention Program, Montreal Heart Institute, Montreal, QC, Canada.

Anita Asgar (A)

Structural Heart Intervention Program, Montreal Heart Institute, Montreal, QC, Canada.

Thomas Modine (T)

Service Médico-Chirurgical: Valvulopathies-Chirurgie Cardiaque-Cardiologie Interventionelle Structurelle, Hôpital Cardiologique de Haut Lévèque, CHU Bordeaux, Bordeaux, France.

Walid Ben Ali (W)

Structural Heart Intervention Program, Montreal Heart Institute, Montreal, QC, Canada.

Classifications MeSH